End-of-day quote
Korea S.E.
06:00:00 2024-05-30 pm EDT
5-day change
1st Jan Change
31,150
KRW
-2.81%
-7.29%
-18.88%
Huons Co., Ltd. completed the spin off medical supply manufacturing business division for KRW 1.1 trillion.
Huons Co., Ltd. (KOSDAQ:A084110) agreed to spin off medical supply manufacturing business division on November 24, 2015. Under the terms of the spin off, for one share of Huons Co., Ltd., 0.5173205 shares of medical supply manufacturing business division will be distributed. The provisional name of the distributing company will be Huons Global Co., Ltd. and the provisional name of the newly established company from the spin-off will be Huons Co., Ltd. The resolution date of Board of Directors of Hulims Co., Ltd is November 24, 2015. The general meeting of stockholders for a spin-off program memorandum approval is scheduled to be held on March 25, 2016. The scheduled date for the spinoff is May 1, 2016.
Huons Co., Ltd. (KOSDAQ:A084110) completed the spin off medical supply manufacturing business division for KRW 1.1 trillion on May 3, 2016. Huons Co., Ltd. changed its name to Huons Global Co Ltd. while Huons Co., Ltd. got listed on KOSE with symbol - A243070.
Huons Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
May. 23
CI
Huons Co., Ltd. authorizes a Buyback Plan.
May. 23
CI
Huons Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 16
CI
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Mar. 26
CI
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 20
CI
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Mar. 17
CI
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.
Jan. 23
CI
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-23
CI
South Korea's Huons to Export Anesthetics to Canada
23-03-01
MT
GenEdit Inc. amended terms of the transaction
23-02-27
CI
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%
22-11-29
MT
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant
22-11-29
MT
GenEdit Inc. announced that it expects to receive $30 million in funding
22-11-08
CI
Haemato : to Seek EU Approval for Botox Product
21-10-25
MT
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor
21-06-10
CI
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor
21-06-02
CI
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors
21-04-18
CI
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
21-03-28
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
21-02-23
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
21-02-23
CI
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.
21-02-17
CI
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd
20-12-10
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
20-11-23
CI
Huons Co., Ltd. announced that it has received KRW 50 billion in funding from a group of investors
20-11-12
CI
Huons Co., Ltd. announced that it expects to receive KRW 50 billion in funding from a group of investors
20-11-10
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Huons Co., Ltd. is a Korea-based company principally engaged in manufacture of general medicine and special medicine.
More about the company
Last Close Price
33,300
KRW
Average target price
54,000
KRW
Spread / Average Target
+62.16%
Consensus
1st Jan change
Capi.
-18.88% 267M +42.24% 739B +32.80% 598B -5.15% 353B +18.02% 318B +5.08% 285B +16.55% 240B +9.53% 210B -5.36% 206B +7.83% 164B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1